RBA proudly announces its partnership with CIOs Against Cancer, marking a significant step forward in the collective fight against cancer. As an Annual Underwriter Sponsor, RBA is aligning its efforts with a community of technology leaders dedicated to leveraging innovation to combat cancer under the banner of #ITAttacksCancer.
Cancer, beyond its profound health implications, is a pressing business concern. Recognizing this reality, CIOs Against Cancer has pioneered a transformative approach to address this issue. As business-focused leaders, CIOs understand the imperative for innovation and collaboration in the fight against cancer.
In 2023, CIOs Against Cancer achieved a remarkable milestone by raising over $600,000, funding three American Cancer Society-approved cancer research projects. Building on this success, the organization aims to surpass that benchmark this year, with a goal of funding four ACS cancer research projects. These efforts underscore the tangible impact of their contributions towards advancing cancer research and treatment.
RBA acknowledges the pivotal role of technology in effecting change and is honored to stand shoulder to shoulder with CIOs Against Cancer in their mission to make a meaningful difference in the lives of those affected by cancer.
Joining this cause is not just an act of philanthropy; it is an investment in the future of healthcare and the well-being of communities worldwide. The data speaks volumes: in 2024, an estimated 35,000 Minnesotans will be diagnosed with cancer, with over 10,000 succumbing to the disease. Such statistics underscore the urgency and significance of collective action.
Noncommunicable diseases (NCDs) like cancer, heart disease, and stroke currently account for 63 percent of deaths globally. Over the next two decades, NCDs are projected to cost the global economy over $47 trillion, emphasizing the economic imperative for combatting these diseases.
Moreover, health-related productivity losses in the United States alone amount to a staggering $225.8 billion annually. Analysis of healthcare expenditures further reveals that while cancer-related diseases constitute only 1 percent of a typical employer’s healthcare claims, they represent 10 percent of healthcare costs.
As we move forward in this partnership, RBA encourages all stakeholders to join the cause and contribute to the collective effort in combating cancer.